ClinicalTrials.gg
RecruitingNCT06537219Updated Aug 5, 2024

Changes in Thoracolumbar Fascia Stiffness and Pain Parameters in Young Patients With Chronic Low Back Pain

An observational study in Pain, Back Pain and Fascia, sponsored by Atılım University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-05.

Primary conditionBack PainRegistry: PainReclassifiedWhy we changed it
Registry
Pain — the first condition term the registry derived for this study.
ClinicalTrials.gg
Back Pain
Why
  1. The study's listed conditions name Back Pain, a narrower term within Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Atılım University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Back Pain with a site in Turkey — 9 open to participants now, 11 under way, none of them phase 3. Back Pain · Turkey.

Planned enrollment
20th of 23
50 · median 110
Started
2024
with 10 others
Observational
23 of 57
4 open now
Primary completion
2024-08
later than 0 of 10 live
Registered
37th of 57
by date

Among the 57 studies in Back Pain with a site in Turkey, this one is the 20th largest by planned enrollment of the 23 observational ones that give a count, is one of 11 that started in 2024, is one of 23 observational ones, reaches primary completion later than 0 of the 10 other live ones, and was the 37th registered.

Back Pain

729 studies on the registry are indexed under Back Pain; 110 are open to participants now.

Browse Back Pain studies →

Open to participants now

9 of the 57 studies in Back Pain with a site in Turkey are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 68 Back Pain studies recruiting now, 29 (43%) set no upper age limit and 32 (47%) stop at 75 or younger; 3 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Back Pain with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to investigate the biomechanical parameters of thoracolumbar fascia (TLF) and pain-related properties including pain intensity, pressure pain threshold (ppt) and pain sensitivity in young adults with non-specific chronic low back pain (LBP), both those experiencing chronic low back pain (LBP) and without LBP.

Read the detailed description

Non-specific low back pain has become a serious public health problem in latest years. The prevalence of low back pain is reported to be 84% in lifetime (1). Recently, an increasing number of studies have reported that fascia, due to its rich nociceptive innervations, may play a role in chronic pain, especially in some non-specific low back pain conditions .

This study will conducted with a total of 50 participant, including those with chronic lower back pain in the experimental group and the control group.

Both groups underwent assessments related to pain properties. Specifically, the Numerical Pain Scale(NMS) will be used to assess subjective pain intensity(4), the Digital Algometer for assessing pressure pain treshold(5), the Pain Sensitivity Scale(PSS) pain sensitivity(6) and the Myotonometer MyotonPRO biomechanical parameters, including stiffness(s), elasticity(d) and tonus (f) of the TFL at the level of Lumbal 1,3 vertebrae(L1,L3) and under 12th costa (7-10). SPSS 23.0 will be used for statistical analysis. p\<0.05 is considered statistically significant.

03

Conditions studied

  • Pain
  • Back Pain
  • Fascia

Browse trials for

Keywords

  • non-spesific back pain
  • thoracolumbar fascia
  • stiffness
  • pain thresold
04

In context

Back Pain Reclassified

729 studies on the registry are indexed under Back Pain; 110 are open to participants now.

This study's planned enrollment of 50 is below the median of 123 across 113 observational studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Atılım University is the lead sponsor of 38 studies on the registry; 16 are open to participants now.

Compared within Back Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Pain. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Academic staff and university students at Atılım University will constitude the study population.

Sample size is calculated with 85% power. 50 participants( 25 experiment,25 control group) will be included in the study

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • chronic back pain participants more than 3 months

Exclusion criteria

Exclusion Criteria:

  • Those with orthopaedic, neurological and systemic diseases will be excluded from the study.
06

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Target follow-up
4 Weeks
Patient registry
Yes

Groups and cohorts

  • back pain group

    participants with chronic back pain( pain duration at least 3 months) aged between 18 and 50 years , male and female participanst will be included in the study. Those with orthopaedic, neurological and systemic diseases will be excluded from the study.

    Other: Assessment

  • control group

    healty male and female participants aged between 18 and 50 years

    Other: Assessment

Interventions

  • OtherAssessment

    Assessment of pain severity,pain thresold of the fascia, pain sensitivity

07

What researchers measure

Primary outcomes

  1. Numerical Pain Scale(NMS

    pain assessment

    Time frame: 1 month

  2. Fascia stiffness

    thoracolumbar fascia stiffness assessment

    Time frame: 1month

  3. the Pain Sensitivity Scale(PSS)

    Pain sensitivity assessment

    Time frame: month

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2024 (actual). Primary completion is estimated for Aug 2024, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2024
First posted
Aug 5, 2024
StartActual
Jul 15, 2024
Primary completionEst.
Aug 30, 2024
CompletionEst.
Sep 15, 2024
Last update
Aug 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06537219
Lead sponsor
Atılım University
Responsible party
NAİME ULUG (Assistant Professor, Atılım University) — Principal investigator
First posted
Aug 5, 2024
Start date
Jul 15, 2024
Primary completion
Aug 30, 2024 (estimated)
Completion
Sep 15, 2024 (estimated)
Last update
Aug 5, 2024

Study contacts

Naime Uluğ, PT,PhD
Contact
ulugnaime@gmail.com
05365434409
Süleyman Korkusuz, PT,PhD
Contact
suleyman.korkusuz@atilim.edu.tr
05388675480

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion